Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-03-11

FDA Approved: GLIPIZIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Glipizide by ANI Pharmaceuticals, approving a generic version of the diabetes medication. It is used to treat type 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glipizide (Glipizide)

Snippet

SUPPL AP for GLIPIZIDE (GLIPIZIDE)